Skip to main content

Table 1 Demographic and clinical characteristics of 158 OSSN patients presenting directly or indirectly to study centres

From: Delay along the care-seeking journey of patients with ocular surface squamous neoplasia in Kenya

Demographic or clinical feature

Direct presenters N = 88

Indirect presenters N = 70

p-valuea

n

(%)

n

(%)

 

Age in years, mean (SD), y

42.5

(12.0)

41.1

(12.0)

0.47c

Sex, No. (%)

    

0.11

 Male

36

(40.9)

20

(28.6)

 

 Female

52

(59.1)

50

(71.4)

 

Marital status, No. (%)

    

0.21

 Single

16

(18.2)

9

(12.9)

 

 Married

55

(62.5)

49

(70.0)

 

 Divorced or Separated

3

(3.4)

6

(8.6)

 

 Widowed

14

(15.9)

6

(8.6)

 

Highest education level, No. (%)

    

0.25

 Completed secondary or higher

33

(37.5)

34

(48.6)

 

 Completed primary or some secondary

33

(37.5)

25

(35.7)

 

 None or some primary

22

(25.0)

11

(15.7)

 

Location of primary occupation, No. (%)

    

0.66

 Indoor

29

(33.0)

26

(37.1)

 

 Outdoor

57

(64.8)

44

(62.9)

 

 Missing data

2

(2.2)

0

0

 

Employment

    

0.23

 Unemployed/no regular income

5

(5.7)

8

(11.4)

 

 Low to middle income

69

(78.4)

58

(82.9)

 

 High income

10

(11.4)

4

(5.7)

 

 Missing data

4

(4.6)

0

0

 

HIV infection/ART use, No. (%)

    

0.42

 HIV-

15

(25.0)

17

(34.0)

 

 HIV+/ART-

15

(25.0)

14

(28.0)

 

 HIV+/ART+

30

(50.0)

19

(380)

 

CD4 count in cells/mm3, median(IQR)

344

(148–802)

219

(120–670)

0.42d

HIV-associated immunodeficiency by CD4 count in cells/mm3, No. (%)

    

0.28

 None or not significant (≥500)

15

(37.5)

14

(34.2)

 

 Mild (350–499)

5

(12.5)

3

(7.3)

 

 Advanced (200–349)

9

(22.5)

5

(12.2)

 

 Severe (<200)

11

(27.5)

19

(46.3)

 

Main symptom, No. (%)

    

0.03

 Lump

53

(60.2)

48

(68.6)

 

 Pain

15

(17.1)

2

(2.9)

 

 Redness

6

(6.8)

8

(11.4)

 

 Others

14

(15.9)

12

(17.1)

 

Tumour diameter in mm, median(IQR)

6.0

(4.3–8.5)

6.0

(4.2–10.0)

0.52d

Histopathology, No. (%)

    

0.87

 CIN I (mild dysplasia)

5

(5.7)

4

(5.7)

 

 CIN II (moderate dysplasia)

13

(14.8)

9

(12.9)

 

 CIN III (severe dysplasia)

19

(21.6)

13

(18.6)

 

 Carcinoma-in-situ

0

0

1

(1.4)

 

 SCC – poorly differentiated

1

(1.4)

1

(1.4)

 

 SCC – moderately differentiated

45

(51.1)

35

(50.0)

 

 SCC – well differentiated

5

(5.7)

7

(10.0)

 

Study Centre, No. (%)

    

<0.001

 Kikuyu Eye Unit

42

(47.7)

55

(78.6)

 

 Kenyatta National Hospital

4

(4.6)

9

(12.9)

 

 Sabatia Eye Hospital

25

(28.4)

3

(4.3)

 

 Kitale District Hospital

17

(19.3)

3

(4.3)

 

Distance from home to study centre or to 1st health facility in km, median(IQR)b

30

(20–89)

20

(5–56)

0.003 d

Cost of care in KSh, median (IQR)

3800

(3800–4800)

3880

(3800–4100)

0.01d

  1. Abbreviations: ART – antiretroviral therapy; CIN – conjunctival intraepithelial neoplasia; SCC- squamous cell carcinoma; KSh – Kenyan shillings
  2. atesting whether the distribution of each demographic feature is the same in direct and indirect presenters
  3. b1 patient had missing data on distance, 48 missing data on HIV and 77 on CD4 count
  4. ct-test with unequal variances
  5. dMann-Whitney U-test